Atlas Trials

A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

Clinical trial NCT00668499 · WITHDRAWN

Trial details

NCT number
NCT00668499
Sponsor
University of Southern California
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Mesothelioma
Start date
2008-04-01
Primary completion
2011-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.